97 related articles for article (PubMed ID: 28676967)
21. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
22. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.
Xiao F; Pu J; Wen Q; Huang Q; Zhang Q; Huang B; Huang S; Lan A; Zhang Y; Li J; Zhao D; Shen J; Wu H; He Y; Li H; Yang X
Oncotarget; 2017 Jul; 8(29):48488-48506. PubMed ID: 28489582
[TBL] [Abstract][Full Text] [Related]
23. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
24. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
25. The link of ERCC2 rs13181 and ERCC4 rs2276466 polymorphisms with breast cancer in the Bangladeshi population.
Sahaba SA; Rashid MA; Islam MS; Nahid NA; Apu MNH; Sultana TN; Chaity NI; Hasan MM; Islam MS
Mol Biol Rep; 2022 Mar; 49(3):1847-1856. PubMed ID: 34837148
[TBL] [Abstract][Full Text] [Related]
26. Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma.
Cui QK; Zhu JX; Liu WD; Wang YH; Wang ZG
Pak J Med Sci; 2014; 30(6):1409-14. PubMed ID: 25674148
[TBL] [Abstract][Full Text] [Related]
27. ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer.
Balkan E; Bilici M; Gundogdu B; Aksungur N; Kara A; Yasar E; Dogan H; Ozturk G
J BUON; 2020; 25(1):574-581. PubMed ID: 32277685
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma.
Dong Y; Zhuang L; Ma W
Tumour Biol; 2013 Apr; 34(2):1155-60. PubMed ID: 23494240
[TBL] [Abstract][Full Text] [Related]
30. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
He MG; Zheng K; Tan D; Wang ZX
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
[TBL] [Abstract][Full Text] [Related]
31. The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model.
Xiao S; Cui S; Lu X; Guan Y; Li D; Liu Q; Cai Y; Jin C; Yang J; Wu S; van der Straaten T
Toxicol In Vitro; 2016 Aug; 34():300-308. PubMed ID: 27139774
[TBL] [Abstract][Full Text] [Related]
32. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Guo L; Wang H; Qi R
Cancer Genet Cytogenet; 2006 Aug; 169(1):27-32. PubMed ID: 16875933
[TBL] [Abstract][Full Text] [Related]
34. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
[TBL] [Abstract][Full Text] [Related]
35. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk.
Bernard-Gallon D; Bosviel R; Delort L; Fontana L; Chamoux A; Rabiau N; Kwiatkowski F; Chalabi N; Satih S; Bignon YJ
Mol Cancer; 2008 May; 7():36. PubMed ID: 18454848
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
37. Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.
Khlifi R; Olmedo P; Gil F; Hammami B; Hamza-Chaffai A; Rebai A
J Appl Genet; 2017 May; 58(2):221-229. PubMed ID: 27838878
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India.
Srivastava K; Srivastava A; Mittal B
Cancer; 2010 Jul; 116(13):3160-9. PubMed ID: 20564624
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
40. Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer.
Rump A; Benet-Pages A; Schubert S; Kuhlmann JD; Janavičius R; Macháčková E; Foretová L; Kleibl Z; Lhota F; Zemankova P; Betcheva-Krajcir E; Mackenroth L; Hackmann K; Lehmann J; Nissen A; DiDonato N; Opitz R; Thiele H; Kast K; Wimberger P; Holinski-Feder E; Emmert S; Schröck E; Klink B
PLoS Genet; 2016 Aug; 12(8):e1006248. PubMed ID: 27504877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
